Wilson Sonsini Goodrich & Rosati is pleased to support the LaunchBio Larger Than Life Sciences Series: Making Your Exit, Strategic Trends to Consider. It is never too early for companies to start thinking about an exit strategy. Identifying and working toward this goal will help founders take the necessary steps to achieve the highest valuation possible. Panelists will discuss the classic IPO path as well as direct offerings, reverse mergers and Special Purpose Acquisition Companies (SPACs) which have become increasingly popular. Learn how to identify and mitigate potential risks that could diminish the value of a company and its intellectual property.
Lori Doyle
ldoyle@wsgr.com
Based in the SOMA and San Diego offices, Mike Hostetler provides strategic IP counseling to growth enterprises in the pharmaceutical and biotechnology, and information technology industries.
Megan Baier has spent her career advising founders, boards, and public companies through the moments that define them: first financings, public offerings, and the governance decisions that follow. A partner in Wilson Sonsini's New York corporate group, she combines deep technical command of securities law with the judgment and steadiness clients need when the stakes are high.